New Developments in Type 1 Diabetes

OR12-1

β-Cell Secretory Capacity and Metabolic Control during 5 Years Following Human Islet Transplantation
Michael R. Rickels, Eileen Markmann, Cornelia Dalton-Bakes, Amy J. Peleckis, Chengyang Liu and Ali Naji

OR12-2

Performance of an Artificial Pancreas System for Young Children with T1D
Mark Daniel DeBoer, Marc D. Breton, Christian Wakeman, Elaine Schertz, Emma G. Emory, Jessica L. Robic, Laura L. Kollar, Boris P. Kovatchev and Daniel R Chernavvsky

OR12-3

Ketones Derived from Dietary Medium-Chain Triglycerides Support Brain Function and Metabolism in Tightly-Controlled Type 1 Diabetic Patients Under Hypoglycemia
Domenico Tricò, Daniel Spicer, Kathleen Page, Renata Belfort De Aguiar, Sarita Naik, Mary Savoye, Jagriti Arora, Lihong Jiang, Douglas Rothman, Todd Constable, Robert Sherwin and Raimund Herzog

OR12-4

Liraglutide Acutely Suppresses Glucagon, Lipolysis and Ketogenesis in Type 1 Diabetes
Manisha Garg, Husam Ghanim, Nitesh D Kuhadiya, Kelly Green, Jeanne Hejna, Barrett Torre and Paresh Dandona

OR12-5

Iron Chelators Are an Effective Treatment for a Relatively Common Cause of Anti-GAD Negative "Type 1Diabetes" - a Founder CISD2 Mutation
David Zangen, Ulla Najwa Abdulhag, Ariella Weinberg-Shukron, Abdulsalam Abulibdeh, Maha Abdulhadi-Atwan, Gil Leibowitz, Ephrat Levy-Lahad, Ola Karmi, Yang-Sung Sohn and Rachel Nechushtai

OR12-6

Elevations in Circulating Extracellular Vesicle Mir-21 As a Biomarker of Developing Type 1 Diabetes Mellitus
Alexander Lakhter, Farooq Syed, Bernhard Maier, Raghavendra G Mirmira, Carmella Evans-Molina and Emily Kristen Sims